Clinical Trial Update: Peg-Granulocyte-Colony Stimulating Factor (GCSF) for Coronary Collateral Growth in Coronary Artery Disease Patients [NA]

View source ↗

Summary

This clinical trial update reports on a completed study evaluating pegylated granulocyte colony-stimulating factor for promoting coronary collateral growth in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Pegylated granulocyte colony-stimulating factor (pegylated granulocyte colony-stimulating factor)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Coronary Artery Disease | NA | Status: COMPLETED